Brief: Ryvu Therapeutics Q3 Net Loss At 24.7 Million Zlotys
20/11/2025 16:56
Nov 20 (Reuters) - Ryvu Therapeutics SA RVU.WA: Q3 NET LOSS AT 24.7 MILLION ZLOTYS Q3 OPERATING REVENUE 61.9 MILLION ZLOTYS Q3 OPERATING LOSS 44.6 MILLION ZLOTYS Source text: ID:nEM8b8NlJa Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project